{"id":"NCT03311945","sponsor":"Judit Pich","briefTitle":"Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM","officialTitle":"Phase 3b, Single Arm, Single Site Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM Clinical Trial (NCT02284035)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-05-02","primaryCompletion":"2021-03-30","completion":"2022-11-30","firstPosted":"2017-10-17","resultsPosted":"2025-07-18","lastUpdate":"2025-07-18"},"enrollment":33,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["HIV Infections","HIV-1-infection","HIV Seropositivity"],"interventions":[{"type":"DRUG","name":"Raltegravir","otherNames":[]},{"type":"DRUG","name":"Lamivudine","otherNames":[]}],"arms":[{"label":"Raltegravir + Lamivudine","type":"EXPERIMENTAL"}],"summary":"Phase 3b, single arm, single site simplification study of HIV-1 infected patients with virological suppression under the combination of Lamivudine (150 mg BID) plus Raltegravir (400 mg BID) switching to Lamivudine (300 mg QD) plus Raltegravir (1200 mg QD): Roll-over study of the RALAM clinical trial (NCT02284035)","primaryOutcome":{"measure":"Proportion of Patients With Therapeutic Failure","timeFrame":"48 weeks","effectByArm":[{"arm":"Raltegravir + Lamivudine","deltaMin":3,"sd":null}],"pValues":[{"comp":"OG000","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":1,"countries":["Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":33},"commonTop":["Gastrointestinal","Systemic","Respiratory","Dermatological","Genitourinary"]}}